COVID-19 (Coronavirus) Update: Testing and Information | Vaccine Updates | Visitor Guidelines

Inhibition of Oral Tumorigenesis by Antitumor B

Protocol No
IIT-WONG-ATB-RANDOMIZED
Principal Investigator
Stuart Wong
Phase
N/A
Summary
This research study is being conducted to determine the effectiveness of Antitumor B (ATB), a botanical agent composed of six Chinese herbs, to slow down tumor growth. ATB is still experimental, meaning it is not approved by the U.S. Food and Drug Administration (FDA). We do not know all the ways that this compound may affect people
Description
IIT-WONG-ATB-RANDOMIZED
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Sub Category